Merck & Company Inc (MRK)

76.41
-0.02(-0.03%)
  • Volume:
    6,904,339
  • Bid/Ask:
    76.00/76.80
  • Day's Range:
    76.03 - 76.78

MRK Overview

Prev. Close
76.43
Day's Range
76.03 - 76.78
Revenue
48B
Open
76.22
52 wk Range
71.73 - 87.76
EPS
2.78
Volume
6,904,339
Market Cap
193.11B
Dividend (Yield)
2.60 (3.41%)
Average Vol. (3m)
11,970,542
P/E Ratio
27.51
Beta
0.43
1-Year Change
-5.1%
Shares Outstanding
2,531,300,247
Next Earnings Date
Apr 29, 2021
What is your sentiment on Merck & Company Inc?
or
Market is currently closed. Voting is open during market hours.

Merck & Company Inc News

Merck & Company Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralNeutral
Technical IndicatorsStrong BuyBuyBuySellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralSell

Merck & Company Inc Company Profile

Merck & Company Inc Company Profile

Employees
74000

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Read More
  • Merk and JJ sounds good to me. Buy and hold.
    1
    • Lots of good news for Keytruda. Buy and Hold!
      0
      • buy and hold we going for long slow ride up
        0
        • Merck (NYSE:MRK) and Ridgeback Biotherapeutics have announced that molnupiravir (EIDD-2801/MK-4482), their investigational oral antiviral agent against COVID-19, managed to speed up the time for the infectious agent to become negative in COVID-19 patients.
          0
          • I was reading about it today, it's a really promising med, and It could be the game changer for this pandemic.!!!! I think the price will skyrocket after the 2nd trial ends.
            0
          • Said Atallah When is the 2nd trial supposed to end and results released?
            0
        • ♧♧♧ red zone
          2
          • what's a good price to pick up? 67?
            1
            • Too late now. 72.00 was the support. It is not going to drop any more before dividends. It may drop on the day dividends are paid or after earning. Who knows?
              0
          • Back in the 80s in next 2 months.
            0
            • 80s? You mean 1980s (cost around 2.5$) or 80$? ))
              1
            • No it will not be in the 80's. I am Long buying in at the 72-73's. It will be luck to even hit 75 & hold there.There are way too many BEARS shorting this stock.
              1
            • Mary MillerNot necessarily; after the uncertainty over the spin off is gone (after Q2), which should improve earnings going forward, price should rise.
              0
          • Breaking: Merck will help Johnson & Johnson in the production of its COVID-19 vaccine.
            0
            • This partnership is historic, they will supply the lower Americas, and beyond.
              0
          • Good news on future.
            0
            • wake up call for market? forward PE value 10, and a good growth story.
              0
              • sign that shorts are abondining this stock; high short interest this month.
                0
              • Good strong support in the range 74-75.
                0
              • not as appealing as many of the zero revenue high flyers
                0
            • Waren Buffet bought this share, He thinks it will rise in March!
              1
              • MRK is a steal at current prices!
                0
                • I could not understand what you mean?
                  0
                • İbrahim Sefa Akgün He meant it is a bargain
                  0
              • Let's Go!
                0
                • Roket cakildi İbooo
                  0
                • roketi kendimize taktık lanet hisse ya
                  0
                • İbrahim Sefa Akgün Endeks 6 ayin en iyi gununu yapti bu -  epik
                  0
              • KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell CarcinomaSat, February 13, 2021, 10:01 AM·56 min readMRK+0.35%
                0
                • Bought more shares today, low multiples, uncertainty will dissipate after the spinoff, and take off again. Money making machine, stable earnings growing steadily. what else do you want from a great company?
                  0
                  • Yes is deep go to 82.5
                    0
                    • is it good time to buy?
                      0
                      • 74 strong support
                        0
                        • time to buy
                          0
                          • ah merck. i bought  from 82.86 usd. -%10
                            0
                            • is this a good entry point?
                              0
                              • Buying at the end of day.
                                0
                              • Ciprian Gal Thanks, I bought some
                                0
                            • Starting to behave like a high beta stock?
                              0
                              • Short interest is very high at the moment. They are shorting the stock hard.
                                0
                                • singulair.... and lawsuits coming...
                                  0
                                  • Price at 100 day support.
                                    0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.